Figure 3.
Results from overnight (12-h) urinary collections for conjugated sex steroids by diagnosis (C, daughter of control mother; P, PCOS mother), number of subjects per group (directly under the diagnosis), and percentage of detectable hormone and Tanner stage. No significant differences between groups in median levels (▪) by Tanner stage were noted.